HITLAB - a leading NYC-based digital health innovation, teaching, and testing lab - for their upcoming 2019 HITLAB Innovators Summit: India on February 16, at IIT Delhi.
Sandoz Inc., a division of Novartis, and Pear Therapeutics, Inc., the leader in prescription digital therapeutics, announced that the U.S. Food and Drug Administration (FDA) has granted clearance for reSET-OTM.